Regarding the last network, there have been reports that show that PI3K/AKT and MEK/ERK signaling pathways are altered in NSCLC and their activation is associated with malignant transformation and drug resistance (Figs. 6 and 7). Here, AKT1 is linked to non-small cell lung carcinoma.